advertisement
Corneal epithelial disorders due to isopropyl unoprostone (unoprostone) eye drops, a prostaglandin F2α-related substance and antiglaucoma agent, have been reported since the agent became commercially available. This in vitro study was performed to clarify the mechanism of cell injury due to unoprostone. After Chang's human conjunctival cells were cultured and exposed for two, four, and eight minutes to 0.03, 0.06, and 0.12% unoprostone and its vehicle containing 1% polysorbate 80, a cell growth assay and DNA histogram analysis using a flow cytometer and scanning electron microscopy were performed. The number of living cells was reduced, and the floating cell number increased immediately after exposure to 0.12% unoprostone for eight minutes. When the cells were cultured for another 48 hours after exposure to unoprostone, the cell number was reduced dose and time dependently. Exposure for two minutes to 0.12% unoprostone showed no effect on the cell cycle. However, exposure for two minutes to 0.12% unoprostone caused alteration of the cell surface, such as reduction of microvilli and filopodia. The vehicle did not affect the cell surface or cell growth. These results suggest that clinically instilled eye drops ofunoprostone can affect cell structure, inhibit cell growth, and gradually cause corneal epithelial disorders.
Dr. M. Oda, Department of Ophthalmology, Kanazawa Medical University, Kahoku, Ishikawa, Japan
11.4 Prostaglandins (Part of: 11 Medical treatment)